PDE4DIP and ovarian carcinoma: The PDE4DIP mutations have also been previously identified in various cancers including lung cancer, medullary thyroid cancer, and ovarian cancer (Chang et al., 2018; Er et al., 2016; Y. Li et al., 2018), but not been reported in leukemia previously.